International Journal of Gynecological Cancer

Article	Citations
Role of pre-diagnostic reproductive factors on long-term (10 years or greater) survival of epithelial ovarian cancer: The Extreme study	309
Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancy	144
Inguinofemoral lymphadenectomy technique in 10 steps	141
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization	106
The Cukurova score in the prediction of primary cytoreduction in ovarian cancer	103
Three-dimensional image of uterine transposition	74
Successful cervical cancer treatment during a monochorionic diamniotic twin pregnancy in a patient with history of preterm delivery	71
Management of stage III and IVa uterine cancer	65
Correction: SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer	65
Well-differentiated papillary mesothelial tumor of the peritoneum	57
A population-based study of outcomes in adjuvant radiotherapy for stage II endometrial carcinoma	56
Complementary use of indocyanine green and technetium to enhance sentinel lymphadenectomy in vulvar cancer	56
Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeins	51
Surgical technique and surgeon volume: the pursuit of data-driven outcomes	46
Primary ovarian leiomyosarcoma: results from an analysis by the French Sarcoma Group (Ovarian SArcoma MAnagement – OSAMA Study)	45
Surgical staging for locally-advanced cervical cancer: the answer remains ‘NO’	45
Computed tomography–based prediction of interval cytoreduction in advanced ovarian cancer	44
Patterns of care and development of quality indicators in patients with non-epithelial and rare ovarian tumors in Australia: insights from the National Gynae-Oncology Registry	43
Epithelial ovarian cancer and borderline tumors during pregnancy: a report from the International Network on Cancer, Infertility, and Pregnancy	43
Utilization of artificial intelligence to mitigate health inequalities in gynecological cancer care	42
22nd meeting of the European Society of Gynaecological Oncology (ESGO 2021) report	42
Evaluating the use of machine learning in endometrial cancer: a systematic review	41
A fully next-generation sequencing-based method of classifying molecular sub-types of endometrial cancer retains prognostic value and expands biomarker targets	41
PARSGO and UM6SS: spearheading excellence in gynecological oncology in Morocco	41
Correspondence on “Immune checkpoint inhibitor combinations for patients with advanced endometrial cancer: a network meta-analysis and cost-utility analysis” by Zhu and colleagues	39

A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC)	39
Management of intravenous leiomyomatosis: a comprehensive review of surgical and perioperative considerations	39
Pocket guide based on the TNM and FIGO staging systems for classifying patients with locally advanced cervical cancer: a practical tool from the GINECO group for quick and easy management	35
Erratum to ‘Controversies in vulvar cancer: revisiting the margin of error’ [International Journal of Gynecological Cancer Volume 35 Issue 3 (2025) 101678]	35
Best original research presented at the 25th European Congress on Gynaecological Oncology: best of ESGO 2024	34
Authors’ response to: “Methodological concerns regarding AGO score validation in low-grade ovarian cancers”	34
O021/#374 Breast cancer patients are at increased risk of devoleping uterine serous cancer: implication for conseling – a seer analysis	34
Patient-initiated follow-up in low-risk endometrial cancer after surgery: a systematic review	34
Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico	33
Use of quadratus lumborum block in gynecologic procedures	33
The Silva Pattern-Based Classification And Oncological Outcomes In Women Undergoing Fertility-Sparing Surgery For Early-Stage Cervical Cancer	31
Homologous Recombination Deficiency (HRD) In P53 Abnormal Endometrial Carcinoma	31
Sarcopenia shortens overall survival of patients with platinum-resistant recurrent ovarian cancer: inverse probability of treatment-weighting analysis	31
Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancer	31
Controversies in the management of mucinous ovarian tumors	30
Does Sentinel Node Know The Cancer Origin? Comparing Sentinel Lymph Nodes Localization In Endometrial And Cervical Cancer	29
Advanced Techniques In Pelvic Exenteration For Cervical Cancer: A Case-Based Surgical Guide	29
PROGNOSTIC FACTORS BASED ON THE MOLECULAR CLASSIFICATION OF ENDOMETRIAL CANCER: SINGLE INSTITUTION STUDY	28
Does The Origin Of Ovarian Cancer Influence Outcomes?	27
Surgical Release Of The Pudendal Nerve By Robotic Approach In 10 Steps	27
Secondary Debulking Followed By Localised Radiotherapy In Patients With Oligometastatic Recurrent Ovarian Cancer – A Case Series Of Two International Cancer Centres	26
The “N-PLUS/NOGGO-Ov53/ENGOT-Ov62-STUDY” To De-Escalate Chemotherapy In Ovarian Cancer: Comparing 3 Vs. 6 Cycles Of Platinum-Based Chemotherapy After Complete Tumor Resection Followed By Niraparib Mai	26
Impact Of Ascites And Peritoneal Metastatic Lesion Volumes, Measured By Newly Developed Deep Learning-Based Algorithm, In Advanced Epithelial Ovarian Cancer	25
A Multivariable Prognostic Analysis For Survival Outcomes In Women With Epithelial Ovarian Cancer - A North Indian Single Centre Study	25
The Prognostic And Predictive Value Of Cardiophrenic Lymph Nodes In Patients Receiving Hyperthermic Intraperitoneal Chemotherapy For Ovarian Cancer In The OVHIPEC-1 Trial	25
Prognostic Factors In Adult Granulosa Cell Tumours Of The Ovary And Long Term Follow-Up. (The Norwegian Radium Hospital Experience 1971-2024)	25
To Compare The Colposcopic Findings By International Federation Of Colposcopy And Cervical Pathology (IFCPC ) Nomenclature And Swede Score For Assessment Of High Grade Cervical Lesions	25
Surgical Treatment Of Advanced Ovarian Cancer: Experience From A Brazilian Cancer Center (Barretos Cancer Hospital) In 2023	25
Prospective Multicentre Evaluation Of Secondary Cytoreductive Surgery In The Era Of PARP-Inhibitors (CONCEPT) In Relapsed Epithelial Ovarian Cancer	24
The Role Of Prehabilitation In ERAS For Gynecologic Oncology In Germany	24
The Role Of Second-Look Surgery In Recurrent Ovarian Cancer Based On The Type Of Relapse	24
Squamous Cell Carcinoma Arising In Mature Cystic Teratomas: A Case Series Review Of Presentation, Treatment, And Prognosis	24
Evaluating The Implementation And Outcomes Of The Tumor-First Testing Strategy For BRCA1/2 Pathogenic Variants In Ovarian Cancer Patients: A Center-Wide Analysis	23
Excision Of Retroperitoneal Mass - Laparoscopic Management Of Iliac Artery Injury	23
Survival Prediction And Mortality Risk Stratification In Ovarian Cancer After NACT: PRGS Outperforms CRS Regression Scoring	23
Trop-2 Expression In Cervical Carcinoma (CX) - A Possible Target For The Antibody Drug Conjugate Sacituzumab	23
A Young Woman Presenting Virilization With Ovarian Mass: A Case Report Of Rare Disease - Ovarian Steroid Tumor	23
Hepatic hilum cytoreductive surgery for ovarian cancer relapse☆	23
Early-Stage Breast Cancer: A Detailed Examination Of Clinicopathological Features	23
Comparative Outcomes Of Excision And Active Surveillance For Cervical Intraepithelial Neoplasia 2 In Women Under 35	23
Impact Of Surgery On Survival Outcomes In Locally Advanced Cervical Cancer Patients With Partial Response After Primary Chemoradiotherapy	22
SPLEEN PRESERVING EXTENSIVE CYTOREDUCTIVE SURGERY	22
Perioperative Outcomes Of Heated Intraperitoneal Chemotherapy For Patients Enrolled In The Feasibility Phase Of A Randomized Controlled Trial: Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy	21
Impact Of Preoperative Conization On The Prognosis Of Cervical Cancer Patients Undergoing Open Abdominal Radical Hysterectomy	21
Vulvar cancer resection with V–Y advancement flap reconstruction	21
Assessment Of The Predictive Role Of Khorana Score And Genomic Profiling In Ovarian Cancer-Related Venous Thromboembolism	21
Clinical Significance Of Low Volume Lymph Node Metastasis In Early Stage Cervical Cancer: A Single Centre Case Series	21
Histological Findings After Completion Hysterectomy And Clinical Outcome Following Conservative Treatment Of Endometrial Carcinoma	21
Safety and management of niraparib monotherapy in ovarian cancer clinical trials	20
Improvement in radiation techniques for locally advanced cervical cancer during the last two decades	20

Growing teratoma syndrome	20
Response to the letter regarding the article “Predictive factors for adnexal involvement in endometrial cancer FIGO stage IIIA”	20
Dual mechanical and pharmacological thromboprophylaxis decreases risk of pulmonary embolus after laparotomy for gynecologic malignancies	20
COST-UTILITY ANALYSIS OF A MOLECULAR-INTEGRATED-PROFILE FOR WOMEN WITH (HIGH)INTERMEDIATE RISK ENDOMETRIAL CANCER - PORTEC-4A AN INTERNATIONAL, MULTICENTRE, RANDOMISED, PHASE 3 TRIAL	19
CERVICAL MELANOMA WITH CEREBRAL DISSEMINATION: A DIAGNOSTIC AND THERAPEUTIC CHALLENGE IN GYNECOLOGIC ONCOLOGY	19
LOWER LIMB LYMPHEDEMA AFTER TREATMENT OF CERVICAL CARCINOMA AND ITS IMPACT ON QUALITY OF LIFE	19
HIDDEN IN PLAIN SIGHT: DESMOPLASTIC SMALL ROUND CELL TUMOUR (DSRCT) PRESENTING AS A GYNAECOLOGICAL MALIGNANCY	19
INTRA-OPERATIVE COMPLICATIONS OF GYNECOLOGIC ONCOLOGY SURGERIES IN A TEACHING HOSPITAL IN SUB-SAHARAN AFRICA: EXPERIENCE FROM ADDIS ABABA, ETHIOPIA	19
HYPOFRACTIONATED RADIATION THERAPY WITH ADAPTIVE PLANNING FOR THE TREATMENT OF ENDOMETRIAL AND CERVICAL CANCER (HERA TRIAL)	19
THE LANDSCAPE OF VULVAR CANCER SURVIVAL AND TREATMENT CHARACTERISTICS IN BOTSWANA	18
A POTENTIAL BLIND SPOT FOR ANTIBODY–DRUG CONJUGATES TARGETING FOLATE RECEPTOR-1	18
SIGNIFICANCE & CLINICAL UTILITY OF 2-DEOXY-2-[18F] FLUORO-D-GLUCOSE-POSITRON EMISSION TOMOGRAPHY HIBRID IMAGING IN THE DIAGNOSIS & RESPONSE EVALUATION IN CERVIX CANCER.	18
PEMBROLIZUMAB PLUS CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB IN PARTICIPANTS WITH PERSISTENT, RECURRENT, OR METASTATIC CERVICAL CANCER: 5-YEAR FOLLOW-UP RESULTS FROM KEYNOTE-826	18
COLPOSCOPIC-HISTOLOGIC DIAGNOSTIC AGREEMENT IN CERVICAL INTRAEPITHELIAL NEOPLASIA 2+: A FIVE-YEAR REVIEW OF COLPOSCOPIC SERVICES AT THE NATIONAL HOSPITAL ABUJA, NIGERIA COLPOSCOPIC-HISTOLOGIC DIAGNOST	18
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study	18
Overall survival after surgical staging by lymph node dissection versus sentinel lymph node biopsy in endometrial cancer: a national cancer database study	17
ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for early-stage cervical cancer	17
2022-RA-828-ESGO A case of 19 years old, female with malignant spindle cell neoplasm; pelvic monophasic synovial sarcoma arising from the pelvic ligaments	17
2022-RA-981-ESGO Can misdiagnosis be avoided in case of intestinal-type carcinoma of the vagina?A literature comprehensive review	17
2022-RA-1495-ESGO Differential metabolism of estrogens in model cell lines and tissues of HGSOC subtypes	17
2022-RA-1127-ESGO The efficacy of MEK inhibitors in the treatment of low-grade serous ovarian cancers: a systematic review	17
2022-RA-630-ESGO Overexpression of PDEA1 is a predictive biomarker for platinum resistance and poor prognosis in epithelial ovarian cancer by regulating cell cycle	17
Use of social media for academic and professional purposes by gynecologic oncologists	17
Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research a	17
2022-RA-1001-ESGO Analysis of postoperative wound infections in malignancies of the female internal tract	17
2022-RA-1690-ESGO Rare uterine cervical adenocarcinomas in salah azaiez institute: clinicopathological features	17
2022-LBA-414-ESGO Preliminary clinical outcome of ADP-A2M4CD8, a next-generation autologous T-cell receptor T-cell therapy, in patients with advanced epithelial ovarian cancer	16
2022-RA-991-ESGO Assessment of high-risk human papillomavirus infections and cervical dysplasia in human immunodeficiency virus-positive pregnant women in germany: a prospective cross-sectional two-ce	16
2022-RA-1387-ESGO Patients with minimal residual disease at upfront debulking surgery have similar survival outcome than patients with complete cytorreduction after neoadjuvant chemotherapy	16
2022-RA-1223-ESGO Cervical cancer in pregnancy: what are the challenges?	16
2022-RA-1019-ESGO Endometrial hyperplasia and cancer: results of two reference hospitals in Ankara	16
2022-RA-1187-ESGO Management and outcomes in high risk GTN – a regional cancer center experience	16
2022-RA-1318-ESGO Immunohistochemical profiling of macrophage subtypes in the microenvironment of ovarian tumours in young women	16
2022-RA-1272-ESGO Cost-effectiveness of risk-reducing surgery for breast and ovarian cancer prevention: a systematic review	16
2022-RA-684-ESGO Factors affecting survival outcomes of patients with clear cell endometrial carcinoma	16
2022-RA-1194-ESGO Efficacy of dostarlimab in endometrial cancer by molecular subtype: a post hoc analysis of the GARNET study	16
2022-RA-1427-ESGO Fertility outcomes following radical trachelectomy for cervical cancer – a single centre ten year retrospective cohort study	16
2022-RA-1245-ESGO Correlation between false negatives of FDG-TEP staging in locally advanced cervical cancer and FIGO 2009 clinical staging system. A retrospective single-center cohort	15
2022-RA-1171-ESGO Total vaginectomy for recurrent gynecological cancer. Experience in kazior	15
Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcoma	15
2022-RA-1604-ESGO Efficiency of simulation program for OB/GYN residents using self-training and supervised sessions: a quantitative study	15
2022-RA-421-ESGO DeflaGyn® has cytotoxic, genotoxic and apoptotic effects on human adenocancer cells: an in vitro study	15
2022-RA-1635-ESGO Accuracy of MRI imaging in preoperative stage assessment of endometrial cancer in determining extension of surgical procedure	15
2022-RA-1191-ESGO Efficacy of a multi-ingredient coriolus versicolor-based vaginal gel in high-risk HPV women over 40: sub-analysis of the paloma clinical trial & papilobs real-life study	15
Performance of molecular classification in predicting oncologic outcomes of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer	15
ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation	14
Preoperative PET Scan Is Associated With Lower Rates Of Adjuvant Treatment In Surgically Treated Cervical Cancer Patients: A 4C Working Group Study	14
ARE ALL MISMATCH REPAIR DEFICIENT ENDOMETRIAL CANCERS CREATED EQUAL? A LARGE, RETROSPECTIVE, TERTIARY CENTER EXPERIENCE.	14
Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer	14
Topographic Distribution Of Histologically Confirmed Pelvic And Aortic Lymph Node Metastasis In Stage IIIC1r Locally Advanced Cervical Cancer: A Spain-GOG Retrospective Study.	14
Deep Dive Into No Specific Molecular Profile (NSMP) Endometrial Cancer: Unraveling Genomic Features According To Estrogen Receptor (ER) Expression	14
Vaginal cuff brachytherapy for endometrial cancer: a review of major clinical trials with a focus on fractionation	14
Robot-assisted utero-ovarian transposition and reanastomosis in vaginal cancer: a step-by-step description technique	14
Urinary Complications Of Bricker Procedures In Oncogynecology: A Monocentric Retrospective Analysis Of 77 Cases Over 20 Years	14
Survival After Incidental Cervical Cancer Diagnosis Following Simple Hysterectomy Compared To Planned Oncological Management In Tumors ≤2 Cm	14
The Role Of Completion Surgery After Menopause In Women With Borderline Ovarian Tumors Treated With Fertility Sparing Surgery - A Multicenter Retrospective Cohort Study	13
Therapeutic Resistance In Synchronous Endometrioid Carcinomas: A Case Report With A Pathogenic Germline Mutation In PMS2	13
Abnormal Uterine Bleeding As A Predictor Of Endometrial Hyperplasia And Cancer Pathology In Postmenopausal Tamoxifen Treated Breast Cancer Patients	13
Solitary Splenic Metastasis In Endometrial Cancer - A Systematic Review And Case Presentation	13
Evaluation Of The MIDKINE Cytokine In Serum, Tumour Tissues And Lymph Nodes Of Patients With Endometrial Cancer	13
Brenner'S Tumors: An Update	13
Obesity In Endometrial Cancer - A Patient Treated With Curative Radiotherapy Using A Custom-Made 3D-Printed Applicator	13
Evaluating Surgical Efficiency In Robotic-Assisted Hysterectomies For Endometrial Cancer And Benign Gynecologic Conditions	13
Technical And Organizational Solutions For Research Endometrial Cancer Data Collection: The Ambispective, Multicentric ENDOCancer-DATA	13
Impact Of Patient Characteristics On Primary Treatment Approach; A Population Based Study Regarding Incidence, Management And Outcome Of Endometrial Cancer Patients In The Netherlands Over 1995-2022	13
CDK7 Inhibition By THZ1 Triggers Pyroptosis And Enhances Immune Response In Ovarian Cancer	13
Comparative Efficacy Analysis Between Adjuvant Vaginal Cuff Brachytherapy And Pelvic External Beam Radiation Treatment For Women With FIGO Stage I Uterine Endometrioid Carcinoma With Pathologic Negati	13
Exceptional Survival And Carcinomatous Recurrence In Mixed Papillary Adenocarcinoma Of The Fallopian Tube: A Clinical Case Report	13
The Impact Of BRCA Status On The Efficacy Of Paclitaxel Monotherapy In Recurrent Ovarian Cancer	12
Journal Information	12
GENE EXPRESSION BASED STUDY TO IDENTIFY POOR PROGNOSTIC INDICATORS IN CARCINOMA CERVIX	12
Comparison Of VNOTES And Laparoscopic Surgery In Patients With Ascites	12
Minimally Invasive Surgery In Early-Stage Ovarian Cancer: Recurrence Analysis	12
Primary Ovarian Malignant Melanoma: A Case Report	12
Impact Of The COVID-19 Pandemic On Ovarian Cancer Diagnosis, Treatment, And Outcomes: A Systematic Review And Meta-Analysis	12
CLINICAL CHARACTERISTICS AND PROGNOSIS OF CLEAR CELL OVARIAN CARCINOMA IN A HOSPITAL IN PERU	12
Evaluation Of Clitoral Artery Doppler Parameters After Brachytherapy And Its Effects On Sexual Functions	12
MANAGEMENT OF A WOMAN WITH CERVICAL MELANOMA: A CASE REPORT AND LITERATURE REVIEW	12
ANTERIOR EXENTERATION FOR MULTIFOCAL VAGINAL CARCINOMA	11
The Impact Of Hyperthermia On Cisplatin Cytotoxicity In Ovarian Cancer Cells	11

Are We Facing A Paradigm Shift In The Treatment Of Advanced Ovarian Cancer? Neoadjuvant Therapy Vs Primary Surgery	11
Parental Knowledge And Health Beliefs Of HPV Vaccination In Kuwait: A Cross-Sectional Descriptive Survey	11
Addition of metronidazole to standard-of-care perioperative prophylaxis at the time of hysterectomy for gynecologic malignancies	11
12-Year Overall Survival And Prognostic Factors In Patients With FIGO Stage IA-IVA Vulvar Cancer Undergoing Surgery ± Adjuvant Radiation Therapy. Results From A Single Eastern European Center.	11
Long Term Outcomes In Patients Treated By Extensive Bowel Resection Due To Advanced Ovarian Cancer	11
Assessing The Implications Of Sentinel Lymph Node Removal In Cervical Cancer: An Immunogenetic Perspective – A SENTICOL/GINECO Ancillary Study	11
Serous-Borderline Ovarian Tumors With Micropapillary Pattern Variants With Microinvasion Mimicking Advanced Stage Ovarian Carcinoma : A Rare Case Report	11
Incidence And Impact Of Low Volume Lymph Node Metastasis In Apparent Early-Stage Ovarian Cancer – MICR-OVARY Study.	11
Treatment Strategies In Advanced Ovarian Cancer: Primary Cytoreductive Surgery And Adjuvant Chemotherapy Versus Neoadjuvant Chemotherapy And Interval Cytoreduction - A Single-Center Retrospective Obse	11
Exploring The Correlation Of Early Sexual Debut On Cervical HPV Infection In LMICs: Insights Through The Lens Of Sustainable Development Goals	11
Squamous Cell Carcinoma Arising From A Mature Cystic Teratoma: A Rare Case	11
Glyoxalase 1: A Promising Biomarker And Target For Cervical Cancer Treatment	11
Is It Time To Revise Cervical Cancer Screening Guidelines?	11
Improving Postoperative Outcomes By Implementing A Gynaecological Oncology-Specific ERAS Pathway In A UK Gynaecological Cancer Centre.	11
HIGH RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA IN A MIDDLE – INCOME SETTING: A RETROSPECTIVE REVIEW OF MANAGEMENT AND OUTCOMES IN A SINGLE TERTIARY INSTITUTION IN SOUTH AFRICA.	10
A RETROSPECTIVE STUDY OF LYMPHADENECTOMY IN PATIENTS WITH ADVANCED OVARIAN CLEAR CELL CARCINOMA	10
Fertility-sparing treatment in early-stage cervical adenocarcinoma: assessing feasibility and limitations	10
COMPREHENSIVE MOLECULAR CHARACTERIZATION OF OVARIAN CANCER: INTEGRATED ANALYSIS OF GENOMIC, HORMONAL, AND IMMUNOLOGIC BIOMARKERS ACROSS TUMOR GRADES AND SUBTYPES	10
EPIDEMIOLOGICAL PROFILE OF MICROINVASIVE DUCTAL CARCINOMA OF THE BREAST	10
A RCT COMPARING THE USE OF LIGNOCAINE SPRAY AND PARACERVICAL BLOCK FOR PAIN RELIEF PRIOR TO LLETZ	10
UPDATES ON THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY (IGCS) GLOBAL FELLOWSHIP PROGRAM	10
TRIAL-IN-PROGRESS: A PHASE II INTERVENTIONAL STUDY OF HPV L1 VACCINE IN COMBINATION WITH IMIQUIMOD AND METFORMIN IN GYNECOLOGIC SQUAMOUS CANCERS	10
Survival outcomes in patients with recurrent mixed sex cord-stromal tumors of the ovary	10
THE MANAGEMENT OF BREAST MELANOMA: EXPERIENCE OF A SINGLE INSTITUTE	10
Oncological outcomes after laparotomic, laparoscopic, and robot-assisted laparoscopic staging for early high–intermediate or high-risk endometrial cancer	10
Advanced ovarian yolk sac tumor: upfront surgery or neoadjuvant chemotherapy followed by interval debulking?	10
Racial and sociodemographic disparities in the use of targeted therapies in advanced ovarian cancer patients with Medicare	10
PATTERNS AND OUTCOMES OF PALLIATIVE RADIOTHERAPY IN ADVANCED VULVAR CANCER IN A HIGH HIV-PREVALENCE SETTING	10
MULTIMODAL PREOPERATIVE OPTIMIZATION IN HIGH-COMPLEXITY GYNECOLOGIC ONCOLOGY SURGERIES: PERSPECTIVES AND OUTCOMES	10
CERVICAL CANCER IN ZIMBABWEAN WOMEN IN THE AWACAN-ED STUDY: EVALUATING THE CLINICO-PATHOLOGICAL CHARACTERISTICS SND FACTORS INFLUENCING STAGE AT PRESENTATION IN WLWH COMPARED TO HIV UNINFECTED WOMEN	10
Pelvic chondrosarcoma presenting as an adnexal mass treated with pubic bone resection	10
The benefit of sentinel lymph node evaluation in pre-operative grade 1 endometrial cancer	10
PRIMARY RECTAL MUCINOUS ADENOCARCINOMA METASTASIS TO THE BREAST IN AN 18-YEAR OLD FEMALE : A CASE REPORT	10
REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN PATIENTS DIAGNOSED WITH ADVANCED ENDOMETRIAL CANCER TREATED WITH IMMUNO-ONCOLOGY THERAPIES IN THE UNITED STATES: 2019-2024	10
OPTIMIZING RADIATION THERAPY DELIVERY IN POST-HYSTERECTOMY PROLAPSE: A CASE FOR VAGINAL PESSARY USE	10
SELECTIVE INTRAOPERATIVE BIOPSY IN ENDOMETRIAL ATYPIA: DEVELOPMENT AND VALIDATION OF A 55/20 RISK SCORE WITH 10-YEAR DIAGNOSTIC AND ECONOMIC OUTCOMES IN CHILE	10
Rising endometrial cancer rates and potential for screening	9
Advanced metastatic G1 endometrioid endometrial carcinoma (no specific molecular profile group)	9
Rare intra-tumoral colonization of Fusobacterium nucleatum in endometrial cancer	9
Opioid and benzodiazepine use in gynecologic oncology patients	9
Proof-of-concept randomized phase II non-inferiority trial of simple versus type B2 hysterectomy in early-stage cervical cancer ≤2 cm (LESSER)	9
Clinical and pathological overview of endometrial endometrioid carcinoma	9
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions	9
Simple perinephric adipose tissue measurement for prediction of failed sentinel lymph node mapping in endometrial cancer	9
Gastric-type adenocarcinoma of the cervix in patients with Peutz-Jeghers syndrome: a systematic review of the literature with proposed screening guidelines	9
Peritoneal cancer index: laparoscopic evaluation of peritoneal carcinomatosis from gynecological origin	9
Expanding the workforce of clinical trial investigators committed to gynecologic cancer research: the GOG Foundation, Inc’s Scholar Career Development Award and New Investigator Program	9
Prognostic impact of para-aortic surgical staging in stage IIIC1 cervical cancer according to the FIGO 2018 classification	9
Response to: Correspondence on 'Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer' by Zhang and Sun	9
Can the Tilburg Frailty Indicator predict post-operative quality of recovery in patients with gynecologic cancer? A prospective cohort study	9
Mirvetuximab soravtansine shines post-PARP inhibitor progression: promising insights from the PICCOLO trial	9
O024/#1151 Trends in clinical trial accrual of underrepresented patients with gynecologic malignancy	9
Correspondence on “Complications of HIPEC for ovarian cancer surgery: evaluation over two time periods” by Navarro Santana et al	9
Correspondence on ‘Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer’ by Luzarraga Aznar et al	9
HPV mRNA testing in cervical cancer screening: implications for low- and middle-income countries	9
Assessing ovarian cancer via laparoscopic video: inter-rater and intra-rater reliability	9
Biomarkers for checkpoint inhibitor therapy in mucinous epithelial ovarian cancer	9
Treatment tolerability associated with carboplatin dose based on actual versus adjusted body weight in patients with a body mass index ≥25 kg/m2 with advanced ovarian cancer	9
Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation	8
The Role Of Vaginal Microbiota And HPV DNA Methylation In Cervical Lesion Progression	8
2022-RA-1180-ESGO Nonfunctional complications associated with radical hysterectomy	8
2022-RA-1114-ESGO BRCA I, BRCA II mutation in high grade ovarian cancers, fallopian tube cancer, primary peritoneal carcinoma	8
2022-RA-816-ESGO The impact of the new RCOG 2019 curriculum and COVID 19 pandemic on gynaecological training amongst the specialist trainees in the United Kingdom: a prospective study	8
2022-RA-1562-ESGO Primary ovarian large B cell lymphoma: About six rare cases	8
2022-RA-1009-ESGO Immune-related endpoints in patients with advanced or recurrent endometrial cancer treated with dostarlimab in the GARNET study	8
2022-RA-1289-ESGO Understanding clinical and pathological heterogeneity of endometrial cancer with no specific molecular profile (NSMP)	8
2022-RA-173-ESGO Endometrioid borderline ovarian tumor: clinical characteristics, prognosis and management	8
2022-RA-1470-ESGO Is neoadjuvant chemotherapy effective as prehabilitation program in advanced epithelial ovarian cancer?	8
2022-RA-1518-ESGO Role of Plastic surgery following resection of vulval tumours: Is collaboration the key?	8
RETRACTED: Role of lymphadenectomy in advanced ovarian cancer—a subgroup analysis of the patients excluded from the LION trial (the Charité cohort)	8
Exploring global barriers to optimal ovarian cancer care: thematic analysis	8
Correspondence on “Use and outcomes of hormonal therapy for advanced stage, low-grade serous ovarian cancer” by Yoh et al	8
2022-RA-845-ESGO Laparoscopic sentinel lymph node mapping in endometrial cancer: A retrospective single center observational study	8
2022-RA-605-ESGO Long term quality of life after chemotherapy among rare ovarian cancer survivors: the national gineco case-control Vivrovaire Rare Tumors study	8
2022-RA-1576-ESGO Deep-learning-based endometrial segmentation and automated immune profiling from histopathological whole slide images	8
2022-RA-1128-ESGO Has endometrial cancer treatment changed during the last years? A cancer registry data-based approach to monitor expected treatment changes after the release of the corresponding S3	8
2022-VA-1166-ESGO Suspicious lymph nodes in advanced ovarian cancer: debulking surgery	8
2022-RA-744-ESGO Hepatitis B screening to reduce the risk of viral reactivation in gynecologic oncology patients receiving chemotherapy at a regional tertiary cancer centre: a quality improvement init	8
2022-RA-1540-ESGO MITO 25.1: a randomized, molecular driven phase II trial of carboplatin-paclitaxel-bevacizumab vs carboplatin-paclitaxel-bevacizumab-rucaparib vs carboplatin-paclitaxel-rucaparib, se	8
2022-RA-711-ESGO Association of PET-CT tumor metabolic metrics and intraepithelial and stromal tumor-infiltrating lymphocytes in locally advanced cervical cancer prior to concurrent chemo-radiotherapy	8
The tug of war: delivering safe gynecologic oncology treatment amid insecurity in Haiti	8
Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer	8
Ascites volume at the time of primary debulking and overall survival of patients with advanced epithelial ovarian cancer	8
2022-VA-739-ESGO Pelvic sentinel lymph node dissection in endometrial cancer	8
2022-RA-1659-ESGO Oncological outcomes of unexpected uterine leiomyosarcomas: a single centre retrospective analysis	8
2022-RA-733-ESGO Duration of HPV persistence and its relationship with recurrent cervical dysplasia	8
2022-RA-1488-ESGO Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer	8
2022-LBA-1708-ESGO Will centralization of ovarian cancer treatment be beneficial in Poland ?	8
2022-VA-1642-ESGO Tricks to improve the laparoscopic extraperitoneal space in para-aortic lymphadenectomy	8
2022-RA-1648-ESGO Cardiophrenic lymph node involvement for ovarian cancer	8
2022-RA-753-ESGO Is laparoscopy a safe approach for treatment of stage II endometrial cancer? A single centre 10 years experience	8
Tailoring treatment for advanced and/or recurrent ovarian cancer using the response of circulating tumor cells to therapy: A retrospective analysis	8
Patients With Endometrial Cancer: Exploring Comorbidities And Quality Of Life – First Results Of An International Survey (NOGGO, ENGOT, GCIG - IMPROVE/EXPRESSION XI)	7
Obstetric And Oncology Outcomes Following Fertility-Sparing Surgery In Non-Epithelial Ovarian Cancer, Epithelial Ovarian Cancer And Borderline Ovarian Tumors: A Systematic Review And Meta-Analysis	7
Novel approaches to managing gestational trophoblastic tumors in the age of immunotherapy	7